Market Tracker

07/26 4:34am ET

Alimera Sciences Inc (NASDAQ:ALIM)

1.45
Delayed Data
As of Jul 25
 -0.01 / -0.68%
Today’s Change
1.03
Today|||52-Week Range
2.40
+34.26%
Year-to-Date

Today’s Trading

Previous close1.46
Today’s open1.48
Day’s range1.41 - 1.49
Volume359,447
Average volume (3 months)402,153
Market cap$94.8M
Dividend yield--
Data as of 07/25/2017

Growth & Valuation

Earnings growth (last year)+8.70%
Earnings growth (this year)+69.05%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)+53.01%
P/E ratioNM
Price/Sales1.66
Price/Book--

Competitors

 Today’s
change
Today’s
% change
LPCNLipocine Inc+0.16+3.26%
GLMDGalmed Pharmaceutica...+0.02+0.26%
OPHTOphthotech Corp+0.06+2.33%
ZFGNZafgen Inc-0.01-0.28%
Data as of 07/25/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$34.3M
Annual profit (last year)-$33.2M
Net profit margin-96.62%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Charles Daniel Myers
President &
Chief Financial Officer
Richard S. Eiswirth
Corporate headquarters
Alpharetta, Georgia

Forecasts